Portacaval shunt in siblings for type I glycogenosis

Insights

Central venous nutrition significantly improved glycogenosis type I in two siblings, enabling successful surgical portal diversion and leading to improved quality of life. Both children are now living relatively normal lives at home.

Area of Science:

  • Biochemistry
  • Pediatric Gastroenterology
  • Metabolic Disorders

Background:

  • Glycogenosis type I (GSD Ia) is a rare inherited metabolic disorder.
  • Patients with GSD Ia experience hypoglycemia and metabolic complications due to impaired glycogenolysis.
  • Effective management strategies are crucial for improving patient outcomes.

Observation:

  • Two siblings diagnosed with glycogenosis type I were studied.
  • Laboratory data were collected before and after 1 month of central venous nutrition (CVN).
  • Postoperative data following surgical portal diversion were also documented.

Findings:

  • Both siblings showed dramatic clinical improvement with CVN.
  • CVN facilitated safe and technically straightforward portacaval shunt surgeries.
  • Patients experienced smooth postoperative recovery periods.

Implications:

  • Central venous nutrition is a viable therapeutic option for managing glycogenosis type I.
  • Surgical interventions like portacaval shunts can be safely performed after nutritional optimization.
  • Improved management strategies can lead to enhanced quality of life for GSD Ia patients.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...